New study aims to uncover hidden dangers in child stem cell transplants
NCT ID NCT05090345
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing 500 children and young adults (up to age 26) who are receiving stem cell transplants. Researchers want to understand why some develop serious blood vessel complications, like blockages or organ failure. By collecting blood samples at several time points, they hope to find early warning signs. This is a research study only, not a treatment, but it could lead to better ways to protect future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict and prevent serious blood vessel problems in children after stem cell transplants.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly benefit participants, and it may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOPOIETIC CELL TRANSPLANTATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Duke University
RECRUITINGDurham, North Carolina, 27705, United States
-
MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Mayo Clinic
RECRUITINGRochester, Minnesota, 55902, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.